{"disease":{"id":"pyruvate-kinase-deficiency-anemia","name":"pyruvate kinase deficiency anemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04902833","title":"Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03548220","title":"A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Agios Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03559699","title":"A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Agios Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04964323","title":"Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO)","phase":"","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Agios Pharmaceuticals, Inc.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}